Journal of Medicinal Chemistry p. 11039 - 11049 (2016)
Update date:2022-08-04
Topics:
Debenham, John S.
Madsen-Duggan, Christina
Clements, Matthew J.
Walsh, Thomas F.
Kuethe, Jeffrey T.
Reibarkh, Mikhail
Salowe, Scott P.
Sonatore, Lisa M.
Hajdu, Richard
Milligan, James A.
Visco, Denise M.
Zhou, Dan
Lingham, Russell B.
Stickens, Dominique
Demartino, Julie A.
Tong, Xinchun
Wolff, Michael
Pang, Jianmei
Miller, Randy R.
Sherer, Edward C.
Hale, Jeffrey J.
The discovery of novel 4-hydroxy-2-(heterocyclic)pyrimidine-5-carboxamide inhibitors of hypoxia-inducible factor (HIF) prolyl hydroxylases (PHD) is described. These are potent, selective, orally bioavailable across several species, and active in stimulati
View MoreXian Changyue Biological Technology Co., Ltd.
website:https://www.xachangyue.com/
Contact:+86-029-62886900
Address:Keji Road NO.70
Shanghai Zhihua ChemTech Co., Ltd.
Contact:+86-13774313779
Address:Room 817 Suite B 3333 Shenjiang Road
Contact:+44 7958 511245
Address:PO Box 469, Manchester, UK
Shandong Wanda Organosilicon New Material Co., Ltd
Contact:+86-21-54177116;54302881
Address:R1318 Greenland No. 3 Lane 58 Xinjian East Rd., Minhang
Contact:027-87677569
Address:Room 2203, yujingmingmen Buidling One, xiongchu Road, wuhan city, hubei province, China
Doi:10.1016/S0040-4020(01)85847-6
(1988)Doi:10.1007/BF00480736
()Doi:10.1007/s11696-016-0127-y
(2017)Doi:10.1039/jr9350001835
()Doi:10.1021/ol006968h
(2001)Doi:10.3184/030823408X390190
(2008)